Aggressive skin cancer subtypes and why Mohs matters

Not all basal and squamous cell carcinomas are alike. Certain subtypes are more aggressive, growing in infiltrative, finger-like extensions rather than as a discrete lump, and these are precisely the tumors where Mohs surgery proves its value.

The pathology report from a skin biopsy often names the subtype, and terms like infiltrative, morpheaform, or micronodular basal cell carcinoma, or poorly differentiated squamous cell carcinoma, flag tumors that spread subclinically, meaning they extend beyond what is visible or palpable at the surface. A standard excision with a fixed margin can easily miss these stealthy extensions, leading to recurrence. Mohs, by examining the complete margin and following the tumor wherever it actually reaches, is far better suited to clearing them in one procedure.

This is why a clinician considers tumor subtype, not just size and location, when recommending treatment, much as they do for tumors in high-risk facial locations. An aggressive subtype, even if small, often warrants Mohs for its thoroughness. For patients, the practical point is that the biopsy result matters: if your skin cancer is described with one of these aggressive-sounding subtypes, the complete margin control of Mohs is especially worth seeking, because these are the tumors most prone to leaving roots behind under ordinary treatment.